U.S., Dec. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07290400) titled 'Effect of Moderate Alcohol on Absorption and Onset of Hezkue Sildenafil Suspension' on Dec. 11.
Brief Summary: This is a Phase 2, open-label, randomized crossover study assessing the effect of moderate alcohol intake on the absorption and onset of action of Hezkue(R) sildenafil oral suspension in adult subjects. Participants will receive Hezkue(R) under different alcohol intake conditions in randomized sequence. Pharmacokinetic sampling and onset assessments will be performed after each administration, and safety will be monitored throughout the study.
Study Start Date: April 15, 2026
Study Type: INTERVENTIONAL
Condition:
Erecti...